Abstract
BackgroundThe effectiveness of immune checkpoint inhibitors in colorectal cancer (CRC) is limited due to the low tumor neoantigen load and low immune infiltration in most microsatellite-stable (MSS) tumors. This study...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have